What's in Chrono Therapeutics, Inc.'s pipeline?

Chrono Therapeutics, Inc. has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Chrono Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: Ottawa Heart Institute Research Corporation, The Scripps Research Institute, US Department of Veterans Affairs, University of California, San Francisco, University of Chicago.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/chrono-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Chrono Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

Chrono Therapeutics, Inc. pipeline: 1 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
NicoDerm CQ Patch	NicoDerm CQ Patch	marketed	Nicotine replacement therapy (NRT)	Nicotinic acetylcholine receptors	Addiction Medicine / Smoking Cessation

Therapeutic area mix

Addiction Medicine / Smoking Cessation · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ottawa Heart Institute Research Corporation · 1 shared drug class
The Scripps Research Institute · 1 shared drug class
US Department of Veterans Affairs · 1 shared drug class
University of California, San Francisco · 1 shared drug class
University of Chicago · 1 shared drug class
University of Maryland, Baltimore · 1 shared drug class
University of Miami · 1 shared drug class
University of Wisconsin, Madison · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Chrono Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). Chrono Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/chrono-therapeutics-inc. Accessed 2026-05-16.